LEADERSHIP

Dr. Olaleye Oginni is the CEO and Founder of ProMed Innovations, a clinical research organisation based in London with a strong commitment to advancing medicine and improving access to cutting-edge treatments.

As a practicing GP and Medical Director with extensive NHS leadership experience, Dr. Oginni brings a unique blend of clinical expertise, operational leadership, and strategic vision to the research space. His career has been defined by building high-performing teams, strengthening governance frameworks, and ensuring that research is delivered with the highest standards of safety and compliance.

Through ProMed Innovations, Dr. Oginni has established a platform dedicated to inclusive research, with a focus on reaching underrepresented communities, particularly within African and Caribbean populations in the UK. He is passionate about creating opportunities for patients to access new therapies while ensuring that clinical trials reflect the diversity of real-world populations.

Dr. Oginni’s leadership combines medical knowledge, regulatory insight, and a patient-first approach, making ProMed Innovations a trusted partner for sponsors, CROs, and patients alike.